Statement of Ownership (sc 13g)
02 Novembro 2022 - 12:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities
Exchange Act of 1934
(Amendment No.________)*
SUNSHINE BIOPHARMA INC.
(Name of Issuer)
COMMON STOCK, par value
$0.001 per share
(Title of Class
of Securities)
867781403
(CUSIP Number)
Malek Chamoun
1730 rue Saint Patrick Apt, 601
Montreal, Quebec, Canada H3K 0B2
(Name, Address and
Telephone Number of Person
Authorized to Receive Notices and Communications)
October 20, 2022
(Date of Event
Which Requires Filing of this Statement)
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
| o |
Rule 13d-1(b) |
| x |
Rule 13d-1(c) |
| o |
Rule 13d-1(d) |
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
| |
| |
|
Malek
Chamoun |
| |
1. |
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Not
Applicable |
| |
| |
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see
instructions) |
| |
|
(a) |
☐ |
| |
|
(b) |
☒ |
| |
| |
3. |
SEC
USE ONLY
|
| |
| |
4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Canada |
| |
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY
EACH
REPORTING PERSON
WITH |
5. |
SOLE
VOTING POWER
3,700,000 |
| |
| 6. |
SHARED
VOTING POWER
0 |
| |
| 7. |
SOLE
DISPOSITIVE POWER
3,700,000 |
| |
| 8. |
SHARED
DISPOSITIVE POWER
0 |
| |
| |
9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,700,000 |
| |
| |
10. |
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see
instructions) ☐
|
| |
| |
11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
16.4% |
| |
| |
12. |
TYPE
OF REPORTING PERSON (see instructions)
IN |
|
| |
|
|
|
|
|
| Item 1. |
| |
(a) |
Name
of Issuer
Sunshine Biopharma Inc. |
| |
(b) |
Address
of Issuer’s Principal Executive Offices
6500 Trans-Canada Hwy
4th Floor
Pointe-Claire,
Quebec, Canada H9R 0A5 |
| |
| Item 2. |
| |
(a) |
Name
of Person Filing
Malek Chamoun |
| |
(b) |
Address
of Principal Office, or if none, Residence
1730 rue Saint Patrick Apt, 601
Montreal, Quebec, Canada
H3K 2H2 |
| |
(c) |
Citizenship
Canada |
| |
(d) |
Title
of Class of Securities
Common Stock |
| |
(e) |
CUSIP
Number
867781403 |
| |
| Item 3. |
If this statement is filed pursuant to § 240.13d-1(b), or 240.13d-2(b) or
(c), check whether the person filing is a: |
| |
(a) |
o |
Broker or dealer registered under section
15 of the Act. |
| |
(b) |
o |
Bank as defined in section 3(a)(6) of the Act. |
| |
(c) |
o |
Insurance company as defined in section 3(a)(19)
of the Act. |
| |
(d) |
o |
Investment company registered
under section 8 of the Investment Company Act of 1940. |
| |
(e) |
o |
An investment adviser in accordance
with § 240.13d-1(b)(1)(ii)(E); |
| |
(f) |
o |
An employee benefit plan or
endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); |
| |
(g) |
o |
A parent holding company or
control person in accordance with § 240.13d-1(b)(1)(ii)(G); |
| |
(h) |
o |
A savings association as defined
in Section 3(b) of the Federal Deposit Insurance Act; |
| |
(i) |
o |
A church plan that is excluded
from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; |
| |
(j) |
o |
Group, in accordance with § 240.13d-1(b)(1)(ii)(J). |
| Item 4. |
Ownership. |
| |
Provide the following information regarding the aggregate number and percentage of
the class of securities of the issuer identified in Item 1. |
|
| |
|
|
| |
(a) |
Amount beneficially owned: 3,700,000 |
| |
(b) |
Percent of class: 16.4% |
| |
(c) |
Number
of shares as to which the person has: 3,700,000 |
| |
|
(i) |
Sole power to vote or direct the vote 3,700,000 |
| |
|
(ii) |
Shared power to vote or to direct the vote 0 |
| |
|
(iii) |
Sole power to dispose or to direct the disposition of 3,700,000. |
| |
|
(iv) |
Shared power to dispose or to direct
the disposition of 0. |
| Item 5. |
Ownership of Five Percent or Less of
a Class.
|
| |
If this statement is being filed to report the fact that
as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities,
check the following ☐. |
|
|
| |
| Item 6. |
Ownership of More than Five Percent on
Behalf of Another Person.
|
| |
Not Applicable. |
| |
| Item 7. |
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the
Parent Holding Company.
|
| |
Not Applicable. |
| |
|
| Item 8. |
Identification and Classification of
Members of the Group.
|
| |
Not Applicable. |
| |
|
| Item 9. |
Notice of Dissolution of Group.
|
| |
Not Applicable. |
| |
|
| Item 10. |
Certifications.
|
| |
(a) |
The following certification shall be included
if the statement is filed pursuant to §240.13d-1(b):
By signing below
I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course
of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that
purpose or effect. |
| |
|
|
| |
(b) |
The following certification shall
be included if the statement is filed pursuant to §240.13d-1(c):
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction having that purpose or effect. |
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
| |
|
|
November
2, 2022 |
|
| |
|
|
Date |
|
| |
|
|
|
|
| |
|
|
/s/
Malek Chamoun |
|
| |
|
|
Signature |
|
| |
|
|
|
|
| |
|
|
Malek
Chamoun |
|
| |
|
|
Name/Title |
|
Sunshine Biopharma (NASDAQ:SBFM)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Sunshine Biopharma (NASDAQ:SBFM)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
